Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Stock Hits 52-Week High

NEW YORK (GenomeWeb News) – Shares of CombiMatrix closed at a 52-week high of $13.31 on Wednesday.
 
Over the past two weeks, shares of the Mukilteo, Wash.-based microarray manufacturer and molecular diagnostics firm have climbed around 20 percent. Year to date, the company’s stock is up nearly 80 percent.
 
Last week, CombiMatrix reported that its second-quarter revenues jumped 55 percent to $2.1 million, driven by diagnostic services revenue.
 
A year ago, the firm completed its split from former parent company Acacia Research as part of an effort to focus on the molecular diagnostics market.
 
 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.